NCT00556010

Brief Summary

Ankle fractures are common injuries that are being operated routinely. In order to restore the long term function and prevent arthritis of the ankle the broken fragments should be put in place precisely. Inadequate reduction can result in pain and long term disability. Recently, based on MRI studies and clinical studies, a significant number of ankle fractures are apparently fixed with less than optimal results. We suggest that the use of a new device that enables better three dimensional imaging will improve the quality of operations performed for ankle fractures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2009

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 8, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 9, 2007

Completed
1.1 years until next milestone

Study Start

First participant enrolled

January 1, 2009

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2011

Completed
Last Updated

July 20, 2012

Status Verified

April 1, 2011

Enrollment Period

2.5 years

First QC Date

November 8, 2007

Last Update Submit

July 19, 2012

Conditions

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with fracture in the ankle with Syndesmosis disruption

You may qualify if:

  • Patients with unstable ankle fractures (as classified by the AO as 44B 44C by Lauge Hansen PER4 or SER4) amenable to open reduction and internal fixation.
  • Patients with syndesmotic rupture as evident from the injury films or during clinical testing in the OR be included in the study.
  • Intraoperative testing will include both a cotton Test and a stress view obtained after bimalleolar fixation has been attained.
  • A positive syndesmotic injury will be defined by the criteria of Pettrone et al as follows: a tib/fib clear space \>5mm or tib/fib overlap of \<10mm (on the AP view), or a tib/fib overlap of \<1mm on the mortise view.

You may not qualify if:

  • Patients with a pilon fracture (i.e. plafond fractures AO type 43B and C) will be excluded even if associated with a fibula fracture and syndesmosis disruption.
  • Patients with contraindications to operative treatment and diabetics
  • Women of childbearing age will be excluded if they present with a positive pre-op Beta HCG test or if they refuse a B HCG test.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hadassah Medical Organization.

Jerusalem, Israel

Location

Related Publications (1)

  • Davidovitch RI, Weil Y, Karia R, Forman J, Looze C, Liebergall M, Egol K. Intraoperative syndesmotic reduction: three-dimensional versus standard fluoroscopic imaging. J Bone Joint Surg Am. 2013 Oct 16;95(20):1838-43. doi: 10.2106/JBJS.L.00382.

MeSH Terms

Conditions

Ankle Injuries

Condition Hierarchy (Ancestors)

Leg InjuriesWounds and Injuries

Study Officials

  • Yorm A Weil, M.D

    Hadassah Medical Organization

    PRINCIPAL INVESTIGATOR
  • Roy Davidovitch, MD

    NYU school of Medicine, Hospital for Joint Diseases , New York, U.S.A

    STUDY CHAIR
  • Rami Mosheiff, MD

    Hadassah Medical Organization

    STUDY CHAIR
  • Kenneth Egol, M.D

    NYU school of Medicine, Hospital for Joint Diseases, New York, USA

    STUDY CHAIR
  • Amal Khoury, MD

    Hadassah Medical Organization

    STUDY CHAIR
  • Meir Liebergall, MD

    Hadassah Medical Organization

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

November 8, 2007

First Posted

November 9, 2007

Study Start

January 1, 2009

Primary Completion

July 1, 2011

Study Completion

July 1, 2011

Last Updated

July 20, 2012

Record last verified: 2011-04

Locations